NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 13275 | Null | 0.0478540623811426 | 0.43843846 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0478540623811426 | 0.3760433 |
NSC 134459 | Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) | 0.0478540623811426 | 0.36729547 |
NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.0478540623811426 | 0.23680164 |
NSC 261726 | ICN 4221 | 0.0478540623811426 | 0.0071021379 |
NSC 319947 | 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- | 0.0478540623811426 | 0.44036829 |
NSC 330507 | Tanespimycin | 0.0478540623811426 | 0.37855183 |
NSC 357885 | Biantrazole | 0.0478540623811426 | 0.13665771 |
NSC 372939 | Null | 0.0478540623811426 | 0.3963328 |
NSC 48526 | Null | 0.0478540623811426 | 0.36756426 |